Results of Annual General Meeting
Released
Released
Announcement PDF
ASX Announcement
Wednesday 15 November 2023
Results of Annual General Meeting
In accordance with Listing Rule 3.13.2, and section 251AA of the Corporations Act 2001
(Cth), Antisense Therapeutics Limited advises the results of its 2023 Annual General Meeting.
All resolutions were carried on a poll. Details of the proxies received and the votes cast on each
resolution are attached.
There were no outstanding questions at the end of the meeting, however, please address any
remaining questions of the Managing Director or the Board via the form at
www.antisense.com.au/contact-us .
Phillip Hains
Company Secretary
This notice is authorised for release to ASX by the board of directors of Antisense Therapeutics Limited.
______________________________________________________________________________________________________
LEVEL 1, 14 WALLACE AVENUE, TOORAK VIC 3142 AUSTRALIA TEL . +61 (3) 9827 8999 FAX +61 3 9859 7701 WEB WWW.ANTISENSE.COM.AU
ANTISENSE THERAPEUTICS LIMITED ABN 41 095 060 745
#
Antisense Therapeutics Limited
Annual General Meeting
Wednesday, 15 November 2023
Results of Meeting
The following information is provided in accordance with section 251AA(2) of the Corporations Act 2001 (Cth) and ASX Listing Rule 3.13.2.
Resolution details
Resolution
Resolution
Type
Instructions given to validly appointed proxies
(as at proxy close)
Proxy's
For
Against
Abstain
Discretion
266,495,749
31,642,816
12,210,768
2,067,036
85.87%
10.20%
3.93%
For
Against
Abstain*
289,331,578
90.31%
31,055,848
9.69%
15,369,679
1. Non-Binding Resolution to Adopt the 2023
Remuneration Report
Ordinary
2. Re-Election of Director - Dr Charmaine
Gittleson
Ordinary
296,809,372
91.90%
13,637,534
4.22%
12,508,318
3.87%
72,776
322,958,792
95.95%
13,637,534
4.05%
12,635,976
3. Ratification of Prior Issue of Shares to
Institutional Investors
Ordinary
214,709,373
91.08%
8,513,165
3.61%
12,519,118
5.31%
40,084,896
240,796,817
96.33%
9,179,832
3.67%
52,054,205
4. Approval for issue of Options to Dr James
Garner
Ordinary
274,538,087
85.76%
26,300,952
8.22%
19,270,422
6.02%
2,918,539
307,622,136
92.19%
26,055,651
7.81%
15,554,515
5. Approval of Employee Share Option Plan
Ordinary
274,074,579
87.81%
25,808,065
8.27%
12,239,743
3.92%
1,193,982
295,264,383
91.46%
27,562,764
8.54%
13,829,958
6. Approval for issue of Options to Dr Charmaine
Gittleson
Ordinary
283,026,254
87.62%
27,692,428
8.57%
12,304,118
3.81%
5,200
307,608,999
91.39%
28,982,127
8.61%
12,641,176
7. Approval of change of Company name and
modification of Constitution
Special
277,780,528
86.70%
39,858,646
12.44%
2,765,350
0.86%
2,623,476
287,724,548
86.96%
43,135,780
13.04%
18,371,974
8. Approval of 10% Placement Facility
Special
298,556,472
92.93%
10,451,247
3.25%
12,271,425
3.82%
1,748,856
322,974,857
96.45%
11,872,613
3.55%
14,384,832
* Votes cast by a person who abstains on an item are not counted in calculating the required majority on a poll.
#
Number of votes cast on the poll
(where applicable)
Resolution
Result
Carried /
Not Carried
Carried
Carried
Carried
Carried
Carried
Carried
Carried
Carried
Share your feedback
Discover